Table 1 Patient clinical characteristics
From: Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lung
Characteristic | All (n = 20) | H-FLAC (n = 12) | L-FLAC (n = 8) |
|---|---|---|---|
Age (years) | |||
Median (range) | 62.5 (31–81) | 64 (35–73) | 51 (31–81) |
Sex, n (%) | |||
Female | 5 (25%) | 3 (25%) | 2 (25%) |
Male | 15 (75%) | 9 (75%) | 6 (75%) |
Smoking status, n (%) | |||
Smoker | 15 (75%) | 9 (75%) | 6 (75%) |
Non-smoker | 5 (25%) | 3 (25%) | 2 (25%) |
T Stage, n (%) | |||
T1 | 9 (45%) | 5 (42%) | 4 (50%) |
T2 | 6 (30%) | 4 (33%) | 2 (25%) |
T3 | 2 (10%) | 0 (0%) | 2 (25%) |
T4 | 3 (15%) | 3 (25%) | 0 (0%) |
N Stage, n (%) | |||
N0 | 18 (90%) | 10 (84%) | 8 (100%) |
N1 | 1 (5%) | 1 (8%) | 0 (0%) |
N2 | 1 (5%) | 1 (8%) | 0 (0%) |
Stage, n (%) | |||
I | 14 (70%) | 8 (67%) | 6 (75%) |
II | 3 (15%) | 1 (8%) | 2 (25%) |
III | 3 (15%) | 3 (25%) | 0 (0%) |
Tumor Size (cm), n (%) | |||
<3 | 9 (45%) | 6 (50%) | 3 (38%) |
≥3 | 11 (55%) | 6 (50%) | 5 (62%) |
